Procedure for content uniformity of enalapril maleate
Buffer solution A
Dissolve 136g of monobasic potassium phosphate in 800mLof water,adjust with phosphoric acid to a pHof 4.0,dilute with water to 1000mL,and mix.
Buffer solution B
Transfer 20.0mLof Buffer solution Ato a 1000-mLvolumetric flask,dilute with water to volume,and mix.
Mobile phase
Prepare a filtered and degassed mixture of water,acetonitrile,and
Buffer solution A(34:15:1).Make adjustments if necessary (see
System Suitabilityunder
Chromatography á621ñ).
Standard preparation
Dissolve an accurately weighed quantity of
USP Enalapril Maleate RSin
Buffer solution Bto obtain a solution having a known concentration of about 100µg per mL.
Test preparation
Transfer one finely powdered Tablet to a 50-mLvolumetric flask,add about 30mLof Buffer solution B,and sonicate for 15minutes.Shake on a mechanical shaker for 30minutes,dilute with Buffer solution Bto volume,sonicate for 30minutes,mix,and filter,discarding the first portion of the filtrate.Dilute a portion of the filtrate with Buffer solution Bquantitatively to obtain a solution containing about 100µg per mL.
Chromatographic system(see Chromatography á621ñ)
The liquid chromatograph is equipped with a 215-nm detector and a 4.6-mm ×20-cm column containing 10-µm packing L7and maintained at a temperature of 80

.The flow rate is about 2mLper minute.Chromatograph the
Standard preparation,and record the peak responses as directed for
Procedure:the capacity factor,
k¢,is not less than 2.5,the column efficiency determined from the analyte peak is not less than 1000theoretical plates,the tailing factor for the analyte peak is not more than 2.0,and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure
Separately inject equal volumes (about 50µL)of the
Test preparationand the
Standard preparationinto the chromatograph,record the chromatograms,and measure the responses for the major peaks.Calculate the quantity,in mg,of C
20H
28N
2O
5·C
4H
4O
4in the Tablet taken by the formula:
(TC/D)(rU/rS),
in which
Tis the labeled quantity,in mg,of enalapril maleate in the Tablet,
Cis the concentration,in µg per mL,of
USP Enalapril Maleate RSin the
Standard preparation,Dis the concentration,in µg per mL,of enalapril maleate in the
Test preparation,based upon the labeled quantity per Tablet and the extent of dilution,and
rUand
rSare the enalapril peak responses obtained from the
Test preparationand the
Standard preparation,respectively.
Procedure for content uniformity of hydrochlorothiazide
Buffer solutionAand Buffer solutionB
Prepare as directed under Procedure for content uniformity of enalapril maleate.
Standard preparation
Transfer about 50mg of
USP Hydrochlorothiazide RS,accurately weighed,to a 200-mLvolumetric flask.Add 20mLof methanol to dissolve the material,dilute with
Buffer solution Bto volume,and mix to obtain a stock solution.Transfer 5.0mLof the stock solution to a 25-mLvolumetric flask,dilute with
Buffer solution Bto volume,and mix to obtain a solution having a known concentration of about 50µg per mL.
Test preparation
Transfer one Tablet to a volumetric flask of a suitable size such that,when the hydrochlorothiazide is dissolved from the Tablet,a solution having a concentration of about 250µg per mLis obtained.Add a volume of Buffer solution Bequal to about half the capacity of the flask,and sonicate with occasional shaking for 15minutes.Shake on a mechanical shaker for 30minutes,dilute with Buffer solution Bto volume,sonicate for 30minutes,mix,and filter,discarding the first portion of the filtrate.Transfer 5.0mLof the clear filtrate to a 25-mLvolumetric flask,dilute with Buffer solution Bto volume,and mix.
Procedure
Determine the absorbances of the
Standard preparationand the
Test preparationin 1-cm cells at the wavelength of maximum absorbance at about 320nm and at 360nm,with a suitable spectrophotometer,relative to
Buffer solution Bas the blank.Calculate the quantity,in mg,of C
7H
8ClN
3O
4S
2in the Tablet taken by the formula:
(TC/D)(A320A360)U/(A320A360)S,
in which
Tis the labeled quantity,in mg,of hydrochlorothiazide in the Tablet;
Cis the concentration,in µg per mL,of
USP Hydrochlorothiazide RSin the
Standard preparation;Dis the concentration,in µg per mL,of hydrochlorothiazide in the
Test preparation,based upon the labeled quantity per Tablet and the extent of dilution;and the parenthetic expressions are the differences in absorbances of the two solutions at the wavelengths indicated by the subscripts for the
Test preparation(
U)and the
Standard preparation(
S),respectively.